Novanta (NASDAQ:NOVT) Updates Q3 2026 Earnings Guidance

Posted by Geri Gentry on Aug 7th, 2026

Novanta (NASDAQ:NOVT – Get Free Report) updated its third quarter 2026 earnings guidance on Wednesday. The company provided EPS guidance of 0.950-1.000 for the period, compared to the consensus earnings per share estimate of 0.940. The company issued revenue guidance of $300.0 million-$304.0 million, compared to the consensus revenue estimate of $263.1 million. Novanta also updated its FY 2026 guidance to 3.680-3.740 EPS.

Novanta Trading Up 2.9%

Shares of NOVT stock opened at $167.98 on Friday. The company has a debt-to-equity ratio of 0.15, a quick ratio of 2.69 and a current ratio of 3.56. Novanta has a 1 year low of $98.27 and a 1 year high of $176.38. The stock has a fifty day moving average of $153.93 and a two-hundred day moving average of $141.42. The firm has a market capitalization of $6.34 billion, a PE ratio of 106.07 and a beta of 1.68.

Novanta (NASDAQ:NOVT – Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The technology company reported $0.89 EPS for the quarter, beating analysts’ consensus estimates of $0.83 by $0.06. The company had revenue of $265.81 million for the quarter, compared to analyst estimates of $262.30 million. Novanta had a return on equity of 11.96% and a net margin of 6.00%.The company’s quarterly revenue was up 10.3% compared to the same quarter last year. During the same period last year, the company earned $0.76 earnings per share. Novanta has set its FY 2026 guidance at 3.680-3.740 EPS and its Q3 2026 guidance at 0.950-1.000 EPS. As a group, research analysts expect that Novanta will post 3.59 EPS for the current year.

Analyst Ratings Changes

Several equities research analysts recently commented on NOVT shares. Wall Street Zen cut Novanta from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. Weiss Ratings reiterated a “hold (c-)” rating on shares of Novanta in a research report on Wednesday, July 15th. Finally, Robert W. Baird set a $180.00 target price on shares of Novanta in a report on Tuesday, June 9th. One investment analyst has rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, Novanta currently has an average rating of “Hold” and a consensus price target of $180.00.

View Our Latest Analysis on Novanta

Insider Transactions at Novanta

In other news, CEO Matthijs Glastra sold 7,500 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $150.43, for a total value of $1,128,225.00. Following the sale, the chief executive officer directly owned 42,761 shares of the company’s stock, valued at approximately $6,432,537.23. This trade represents a 14.92% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 1.20% of the company’s stock.

Institutional Investors Weigh In On Novanta

Several hedge funds and other institutional investors have recently modified their holdings of the stock. AQR Capital Management LLC increased its position in Novanta by 78.9% during the first quarter. AQR Capital Management LLC now owns 4,231 shares of the technology company’s stock worth $537,000 after acquiring an additional 1,866 shares during the period. Goldman Sachs Group Inc. boosted its holdings in Novanta by 1.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 419,037 shares of the technology company’s stock valued at $53,582,000 after purchasing an additional 6,533 shares during the period. Jane Street Group LLC boosted its holdings in Novanta by 1,762.5% in the 1st quarter. Jane Street Group LLC now owns 61,631 shares of the technology company’s stock valued at $7,881,000 after purchasing an additional 58,322 shares during the period. First Trust Advisors LP acquired a new stake in Novanta in the 2nd quarter worth $528,000. Finally, Amundi grew its position in Novanta by 2.0% in the 2nd quarter. Amundi now owns 18,042 shares of the technology company’s stock worth $2,397,000 after purchasing an additional 347 shares during the last quarter. Institutional investors and hedge funds own 98.35% of the company’s stock.

About Novanta

(Get Free Report)

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.